MapLight Therapeutics, Inc. SEC filings MPLT

MapLight Therapeutics, Inc. has 209 filings in SEC EDGAR's recent list, going back to Mar 8, 2019. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (material agreement, results of operations, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.

MapLight Therapeutics, Inc. SEC filings
Form Description Filed Period
EFFECT Filing Sep 23, 2026 —
CERT Filing Oct 24, 2025 —
8-A12B Filing Oct 24, 2025 —
DRSLTR Filing Aug 22, 2025 —
DRS/A Filing Aug 22, 2025 —
UPLOAD Letter from the SEC Aug 12, 2025 —
DRS/A Filing Jul 30, 2025 —
D Filing Jul 28, 2025 —
DRSLTR Filing May 10, 2024 —
DRS/A Filing May 10, 2024 —
UPLOAD Letter from the SEC Apr 24, 2024 —
DRSLTR Filing Apr 12, 2024 —
DRS/A Filing Apr 12, 2024 —
UPLOAD Letter from the SEC Apr 4, 2024 —
DRS Filing Mar 8, 2024 —
D/A Filing Nov 3, 2023 —
D Filing Jul 19, 2023 —
D Filing Nov 10, 2022 —
D Filing Mar 10, 2021 —
D Filing Sep 4, 2019 —
D/A Filing Mar 22, 2019 —
D Filing Mar 8, 2019 —

Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MPLT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Redwood City, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1770069
Former names
Alvarado Therapeutics, Inc. (until Mar 22, 2019)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.